{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:09:48Z","timestamp":1791684588508,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T00:00:00Z","timestamp":1353542400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>To investigate whether or not coadministration of tacrolimus (TAC) with prednisolone (PSL) can produce a beneficial effect in the treatment of polymyositis\/ dermatomyositis (PM\/DM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We reviewed medical records of 32 PM\/DM patients who had been admitted to our hospital, and abstracted those who had received TAC in addition to oral PSL for treatment. The clinical usefulness of TAC in PM\/DM was objectively evaluated focusing upon the manual muscle strength test (MMT) score, serum creatine kinase (CK) and tapering of PSL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nine patients with PM and 6 with DM were enrolled in this study. TAC was added because of difficulty in reduction of PSL in 12 patients and recurrence with corticosteroid-induced complications in the remaining 3. Both PM and DM patients showed significant increases in the MMT score and significant decreases in serum CK 1 to 3\u2009months after starting TAC compared with before. Skin symptoms in a clinically amyopathic DM patient also improved 1\u2009month after starting TAC. The daily dosage of PSL could be significantly reduced in both PM and DM after starting TAC compared with before. No serious adverse events ascribable to TAC occurred in any patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Additional use of TAC with PSL may safely promote improvement of PM\/DM and also accelerate tapering of the latter.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-13-228","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T21:14:55Z","timestamp":1353618895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis\/ dermatomyositis: a retrospective study"],"prefix":"10.1186","volume":"13","author":[{"given":"Yasuhiro","family":"Shimojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-ichi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,22]]},"reference":[{"key":"1607_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975, 292: 344-347. 10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"1607_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","volume":"13","author":"SL Schreiber","year":"1992","unstructured":"Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992, 13: 136-142. 10.1016\/0167-5699(92)90111-J.","journal-title":"Immunol Today"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jocn.2004.12.008","volume":"13","author":"Y Shimojima","year":"2006","unstructured":"Shimojima Y, Matsuda M, Gono T, Ishii W, Tokuda T, Ikeda S: Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone. J Clin Neurosci. 2006, 13: 39-44. 10.1016\/j.jocn.2004.12.008.","journal-title":"J Clin Neurosci"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R: Polymyositis and dermatomyositis. Lancet. 2003, 362: 971-982. 10.1016\/S0140-6736(03)14368-1.","journal-title":"Lancet"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/ard.2003.017715","volume":"64","author":"M Aleksza","year":"2005","unstructured":"Aleksza M, Szegedi A, Antal-Szalm\u00e1s P, Irinyi B, Gergely L, Ponyi A, Hunyadi J, Sipka S, Zeher M, Szegedi G, Dank\u00f3 K: Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis. 2005, 64: 1485-1489. 10.1136\/ard.2003.017715.","journal-title":"Ann Rheum Dis"},{"key":"1607_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2169\/internalmedicine.47.0967","volume":"47","author":"W Ishii","year":"2008","unstructured":"Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S: Flow cytometric analysis of lymphocyte subpopulations and TH1\/TH2 balance in patients with polymyositis and dermatomyositis. Intern Med. 2008, 47: 1593-1599. 10.2169\/internalmedicine.47.0967.","journal-title":"Intern Med"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar2139","volume":"9","author":"C Grundtman","year":"2007","unstructured":"Grundtman C, Malmstr\u00f6m V, Lundberg IE: Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther. 2007, 9: 208-10.1186\/ar2139.","journal-title":"Arthritis Res Ther"},{"key":"1607_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2169\/internalmedicine.42.1253","volume":"42","author":"Y Shimojima","year":"2003","unstructured":"Shimojima Y, Ishii W, Kato T, Hoshi K, Matsuda M, Hashimoto T, Tanaka Y, Ikeda S: Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med. 2003, 42: 1253-1258. 10.2169\/internalmedicine.42.1253.","journal-title":"Intern Med"},{"key":"1607_CR9","first-page":"1527","volume":"26","author":"Y Nawata","year":"1999","unstructured":"Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I: Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine. J Rheumatol. 1999, 26: 1527-1533.","journal-title":"J Rheumatol"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00002281-200011000-00005","volume":"12","author":"M Hirakata","year":"2000","unstructured":"Hirakata M, Nagai S: Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000, 12: 501-508. 10.1097\/00002281-200011000-00005.","journal-title":"Curr Opin Rheumatol"},{"key":"1607_CR11","first-page":"58","volume":"32","author":"T Fujisawa","year":"2005","unstructured":"Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H: Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol. 2005, 32: 58-64.","journal-title":"J Rheumatol"},{"key":"1607_CR12","volume-title":"Muscle testing: techniques of manual examination","author":"L Daniels","year":"1980","unstructured":"Daniels L, Worthingham C: Muscle testing: techniques of manual examination. 1980, Philadelphia: WB Saunders Co, 4","edition":"4"},{"key":"1607_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD: A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006, 54: 597-613. 10.1016\/j.jaad.2005.10.041.","journal-title":"J Am Acad Dermatol"},{"key":"1607_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/rheumatology\/kep097","volume":"48","author":"LE Waite","year":"2009","unstructured":"Waite LE, Madhok R: Tacrolimus - a potential therapy for polymyositis?. Rheumatology (Oxford). 2009, 48: 858-859. 10.1093\/rheumatology\/kep097.","journal-title":"Rheumatology (Oxford)"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","volume":"27","author":"J Hassan","year":"2008","unstructured":"Hassan J, van der Net JJ, van Royen-Kerkhof A: Treatment of refractory juvenile dermatomyositis with tacrolimus. Clin Rheumatol. 2008, 27: 1469-1471. 10.1007\/s10067-008-0973-2.","journal-title":"Clin Rheumatol"},{"key":"1607_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2169\/internalmedicine.44.1197","volume":"44","author":"T Mitsui","year":"2005","unstructured":"Mitsui T, Kuroda Y, Kunishige M, Matsumoto T: Successful treatment with tacrolimus in a case of refractory dermatomyositis. Intern Med. 2005, 44: 1197-1199. 10.2169\/internalmedicine.44.1197.","journal-title":"Intern Med"},{"key":"1607_CR17","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","volume":"353","author":"CV Oddis","year":"1999","unstructured":"Oddis CV, Sciurba FC, Elmagd KA, Starzl TE: Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet. 1999, 353: 1762-1763. 10.1016\/S0140-6736(99)01927-3.","journal-title":"Lancet"},{"key":"1607_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.10018","volume":"25","author":"A Evoli","year":"2002","unstructured":"Evoli A, Di Schino C, Marsili F, Punzi C: Successful treatment of myasthenia gravis with tacrolimus. Muscle Nerve. 2002, 25: 111-114. 10.1002\/mus.10018.","journal-title":"Muscle Nerve"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0041-1345(03)00765-6","volume":"35","author":"K Falkiewicz","year":"2003","unstructured":"Falkiewicz K, Nahaczewska W, Boratynska M, Owczarek H, Klinger M, Kaminska D, Wozniak M, Szepietowski T, Patrzalek D: Tacrolimus decreases tubular phosphate wasting in renal allograft recipients. Transplant Proc. 2003, 35: 2213-2215. 10.1016\/S0041-1345(03)00765-6.","journal-title":"Transplant Proc"},{"key":"1607_CR20","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1002\/art.11363","volume":"48","author":"DE Yocum","year":"2003","unstructured":"Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA: Tacrolimus rheumatoid arthritis study group. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis. A double-blind trial. Arthritis Rheum. 2003, 48: 3328-3337. 10.1002\/art.11363.","journal-title":"Arthritis Rheum"},{"key":"1607_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mus.10472","volume":"28","author":"T Konishi","year":"2003","unstructured":"Konishi T, Yoshiyama Y, Takamori M, Yagi K, Mukai E, Saida T: Japanese FK506 MG study group. Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve. 2003, 28: 570-574. 10.1002\/mus.10472.","journal-title":"Muscle Nerve"},{"key":"1607_CR22","first-page":"243","volume":"31","author":"H Kondo","year":"2004","unstructured":"Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S: Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. J Rheumatol. 2004, 31: 243-251.","journal-title":"J Rheumatol"},{"key":"1607_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/rheumatology\/keh155","volume":"43","author":"DE Yocum","year":"2004","unstructured":"Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group: Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford). 2004, 43: 992-999. 10.1093\/rheumatology\/keh155.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-13-228\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-13-228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:59:10Z","timestamp":1630533550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-13-228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-13-228","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,22]]},"assertion":[{"value":"18 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"228"}}